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Abstract 
  BACKGROUND: This study aimed to determine the role and effects of baroreflexes during 
acute increase in blood pressure (BP) after severe and long-term infusion of morphine. 
 METHODS:  This experimental study was conducted on male desert rats. They were assigned 
into 4 groups and the rats of the case group received morphine in the short and long term 
periods, whereas the control rats received normal saline for the same duration. Then, the rats 
were anesthetized, and their femoral artery and vein were cannulated for the injection of 
phenylephrine and naloxone, respectively. The injection of phenylephrine was performed by the 
device after a period of recording BP, mean arterial pressure (MAP), heart rate (HR) and 
baroreflex sensitivity (BRS) in order to induce acute hypertension before and after injecting 
naloxone. The Student t-test and analysis of variance (ANOVA) were used for statistical analysis. 
 RESULTS: The obtained results suggested that acute and chronic injections of morphine may 
cause significant reduction in systolic and diastolic arterial BP as well as the mean arterial 
pressure; moreover, it significantly increased the sensitivity of baroreflexes. Furthermore, the 
increased baroreflex sensitivity was observed after acute injection of morphine, whereas chronic 
morphine injection caused reduction in baroreflex sensitivity. 
  CONCLUSION: It seems that the details of the opiates' effects on the body including 
cardiovascular system depend on the type of opioids and consequently, on the type of stimulated 
receptor. 
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Introduction 
Long-term morphine use can impair the normal 
function of the central nervous system. These 
disruptions occur in a wide area of the brain; and 
cardiovascular control centers are not excluded from 
these changes and the function of these centers are 
also undergoing changes.1,2 Given the increasing 
prevalence of drug abuse in most societies, finding 
practical solutions for quitting the addiction is the 
subject of many common worldwide investigations. 
Current approaches used to treat addicts typically 
have not achieved much success and unfortunately, 
most addicts have turned to drug addiction after the 
quitting procedures again.3 Cardiovascular problems 
in addicted people are the most important factors in 
their deaths especially when the drug is suspended. 
Studies have shown that long-term consumption of 
morphine may change the performance of these 
centers. Acute morphine consumption as well as 
peripheral vasodilatation led to decrease in systemic 
blood pressure (BP). This effect was associated with 
inhibition of baroreceptor and respiratory depression 
reflexes and sometimes led to cardiac arrest and 
respiratory problems.4 Studies have shown that the 
intravenous (IV) acute injection of morphine in 
rabbits caused hypertension, bradycardia, and 
hyperglycemia.5,6 Moreover, injection of high doses of 
intrathecal morphine in dogs caused hypertension.7 
  In other studies, IV injection of dynorphin and 
beta-endorphins caused hypotension.8,9 The effect of 
hypotension along with bradycardia due to 
subcutaneous injection of morphine in the group of 
hypertensive rats can be seen more than those with 
normal pressure10-12. In addition to direct effects, 
there are other studies about the indirect effects of 
morphine during the quitting period. For instance, Effects of morphine on the cardiovascular system 
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depending on the injection time of endomorphin 2, 
medial nucleus tractus solitarius (MNTS) can have a 
stimulating or inhibitory effect on baroreflex and as a 
result on the blood pressure.13 Another study also 
showed that opioids and gabaergic systems in the 
MNTS have an inhibitory effect on baroreflex.14,15 It 
is expected that endomorphins to have inhibitory 
effects on neurons and to increase blood pressure and 
heart rate.16-18 On the other handو it seems that the 
baroreflex sensitivity(BRS) will be decreased by 
activation of baroreceptor which causes the release of 
an opioids peptide in the brainstem and the increase 
of BRS, and also the activation of peripheral opioids 
possibly through preventing the release of 
norepinephrine from neurons of the heart.19 
Therefore, because of existing controversies, and in 
order to find a solution to reduce the cardiovascular 
effects of morphine withdrawal syndrome, the current 
study was designed to determine the role and effects 
of baroreflexes during acute increase in BP after acute 
and long-term infusion of morphine. 
Materials and Methods 
This study had an experimental design. It was 
conducted on male wistar rats weighing 250 ± 20 
grams. The rats were assigned into 4 groups (ten 
pieces) by simple random sampling method. The first 
group received short-term morphine and the second 
group was recipient of long-term morphine while the 
third and the fourth group received normal saline in 
short and long term periods. After receiving the desired 
amount and during the predicted time, each group was 
anesthetized by intraperitoneal (IP) urethane injection 
with a dosage of 150 mg/100g. Then, tracheal 
intubation was performed. The femoral vein was 
cannulated in order to infuse phenylephrine and 
naloxone. The femoral artery was cannulated in order 
to record blood pressure and heart rate. After a 
recording period of BP, mean arterial pressure (MAP), 
heart rate (HR) and BRS, the injection of 
phenylephrine was performed to induce acute 
hypertension before and after injecting naloxone.  
  The values of BP, MAP, HR and BRS were 
recorded before, during and after phenylephrine and 
naloxone injection. The BRS (ΔHR/ΔMAP) index 
was used to assess the performance of 
baroreceptors.20 In the first group, i.e., the group 
receiving short-term (acute) morphine, the IP 
morphine chloride solution was injected 3 times, 20, 
40 and 60 mg per kg, respectively, at the time of 
testing. After each injection, changes in BP, MP, HR 
and BRS were measured. The mentioned factors were 
also studied in the sharp rise of BP and after receiving 
phenylephrine with the dosage of 6 μg/kg in two 
stages, after the injection of morphine and naloxone. 
In the second group, i.e., the group of long-term 
(chronic) morphine recipient, in 9 days IP morphine 
chloride solution was injected, 20 mg/kg in the first 
3 days, 40 mg/kg in the second 3 days and 60 mg/kg 
in the third 3 days. On the tenth day BP, MAP, HR 
and BRS were recorded after anesthesia for 
comparing the changes with those of the acute 
group. These changes were recorded in order to 
assess the response to an acute increase in BP before 
and after the injection of phenylephrine in the phase 
of drug addiction before naloxone injection and in 
the phase of quitting, after naloxone injection. 
  An amount of 0.2 cc normal saline solution was 
injected to the third group (control group) rather than 
short-term injection of morphine chloride solution 
and the mentioned parameters were measured like the 
sample group. The rats injected by urethane with the 
dose of 150 mg/100g and were anesthetized with IP 
injection. After the skin incision and pushing aside 
the appeared fascia of skin, the femoral artery and 
vein were exposed and a tiny cut was created by using 
a pair of special scissors in an appropriate place of 
femoral artery under a stereomicroscope. Then, the 
artery was cannulated through a polyethylene tube 
with OD (outside diameter) = 0.97 mm and the entry 
point of cannula into the artery was fixed with suture. 
  Then, the relevant cannula which was heparinized 
with a heparin concentration of 0.5/40 was connected 
to Power lab device after the bubble mark for 
recording HR, BP, MAP and BRS. Similarly, the 
femoral vein was cannulated and the respective 
cannula was also connected to an insulin syringe 
containing phenylephrine solution (6 mg/kg), for 
injecting to the rats. In the next step, to create the 
proper way to breathe during the test, the rat trachea 
connected to another special polyethylene pipe with 
an equal approximate diameter of the cannulated rat 
tracheal diameter. After fixing the endotracheal tube, 
the incision site of the artery and vein cannulation were 
stitched. It is worth mentioning that the rat body 
temperature was kept constant at 37 ± 0.5 degrees of 
Celsius during all above stages. BP and HR were also 
recorded during the study period. Data were collected 
and calculated through the Power lab device and Chart 
5 software by using the Student-t test and analysis of 
variance (ANOVA). 
Results 
In this study, 40 rats were studied in four groups. The 
mean comparison of systolic and diastolic arterial 
pressure and mean arterial pressure during acute 
increase in blood pressure before receiving morphine 
and after receiving acute morphine and naloxone are   A.A. Pour Shanazari, Z. Aslani, E. Ramshini, H. Alaei 
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shown in Figure 1. It was observed that the systolic 
and diastolic BP and MAP were decreased by 
receiving acute morphine and also after obtaining 
naloxone and the rate of decline in on all three cases 
were more than that in the other modes after 
receiving the acute morphine (P < 0.05). But, the 
difference between systolic and diastolic BP and 
MAP was not statistically significant after receiving 
the naloxone (P > 0.05). The mean BRS during 
increased acute BP was compared before receiving 
morphine and after receiving acute morphine and 
after receiving the naloxone in Figure 2. The figure is 
showing that the BRS declined after receiving the 
acute morphine and also obtaining the naloxone and 
this amount of reduction was more than that of the 
other mode after receiving the acute morphine but  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Comparing changes in systolic and diastolic pressures and mean arterial pressure before and after morphine 
injection and after naloxone administration (0.3 mg/kg) in rats 
: P < 0.05* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Comparison of changes in baroreflex sensitivity during the acute blood pressure before and after receiving 
morphine, after receiving chronic morphine and naloxone (0.3 mg/kg) in rats 
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Figure 3. Comparison of changes in systolic and diastolic pressures and mean arterial pressure during acute increase in 
blood pressure before and after receiving morphine and acute morphine injection (20 mg/kg) and after naloxone 
administration (0.3 mg/kg) in rats 
 
in neither of these two modes, the reduction in the 
mean BRS was statistically significant (P > 0.05). 
  The average systolic and diastolic BP and MAP are 
shown during acute increase in blood pressure before 
receiving morphine and after obtaining acute 
morphine and also after receiving naloxone in Figure 
3. The comparison diagram shows that systolic and 
diastolic arterial pressure and mean arterial pressure 
were decreased significantly after receiving the acute 
morphine compared with the case before obtaining 
the morphine (P <0.01). This diagram also shows that 
systolic and diastolic BP and MAP were increased 
after receiving the naloxone compared to the case 
before receiving the morphine but this increase was 
not statistically significant in the above cases   
(P > 0.05). The comparison of mean BRS during 
acute BP increase is shown in Figure 4 before 
receiving morphine and after receiving acute 
morphine and also after receiving naloxone. It was 
observed that the BRS increased after receiving the 
acute morphine compared to the case before 
receiving the morphine (P < 0.01). The figure also 
shows that the BRS increased after receiving the 
naloxone compared to the case before receiving the 
morphine, but this increase was not statistically 
significant (P > 0.05). 
Discussion 
The results of this study showed that acute morphine 
injecting caused significant reduction in systolic and
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Comparing changes in systolic and diastolic pressures and mean arterial pressure before and after morphine injection 
and after naloxone administration (0.3 mg/kg) in rats: P < 0.05* 
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diastolic arterial BP and MAP, while it had not any 
strong effect on HR and BRS. Furthermore, the acute  
injection of morphine caused not only a significant 
reduction in systolic and diastolic arterial BP, MAP 
and HR, also a significant increase in BRS. Details of 
opioids effects on the body including the 
cardiovascular system are dependent on the type of 
opioid agent and consequently, the type of stimulated 
receptor. For instance, Fontana and colleagues 
showed that in the hypertensive patients, the 
endogenous opioids are responsible for high BP 
(including three main categories: encephalin: The 
Delta receptor agonist - Beta-endorphins: Mu and 
Kappa and Delta strong agonist receptors - 
dynorphin: Kappa strong receptor agonist and Mu 
relatively strong antagonist) by creating stimulatory 
effects.21 Comparison of the above results revealed 
that both acute and chronic morphine consumption 
significantly reduced the arterial pressure. Significant 
effect on increasing BRS was only observed in acute 
morphine injection cases and this effect was reverse 
in chronic morphine injection though, this reduction 
was not statistically significant. 
  Similarly, Lee and colleagues showed that IV acute 
form of morphine injection (3 mg/kg) in rabbits 
caused hypertension (HTN).14 In another study, the 
same researchers showed that ICV injection of 
morphine in rabbits would cause hypertension, 
bradycardia, hyperglycemia, respiratory depression 
and increased adrenaline while the IC injection of the 
same dose of morphine did not create significant 
increase in BP and adrenaline levels. IV injection of 
naloxone had no blocking effects on hypertension, 
hyperglycemia and increased catecholamine but it 
blocked the morphine-induced respiratory 
depression.15 High-dose intrathecal morphine 
injection caused hypertension in dogs.16 However, our 
results showed that the acute injection of morphine 
reduced the systolic and diastolic BP and MAP. The 
results are in line with the results of other studies 
which confirmed that the IV injection of dynorphin 
and beta-endorphins can cause hypotension.17,18 
Another study on 144 ventilated neonates with severe 
asphyxia and severe intraventricular hemorrhage and 
major congenital anomalies showed no significant 
differences in MAP of the two groups receiving either 
morphine or placebo. Although the severity of 
hypotension in the group receiving morphine 
infusions was higher than that of the control group 
but, the use of blood volume enhancers and 
vasoconstrictor drugs did not establish a clear 
difference in the results of studied groups.22 However, 
intravenous injection of morphine in rats decreased 
HR, but had no any clear effect on arterial BP.23 We 
found both acute and chronic morphine injection 
created BP changes in order to reduce the pressure. 
  The involved mechanism is not properly known in 
BP changes following the acute and chronic injections 
of morphine. Many researches have been performed 
in this regard. For example the role of BRS in creating 
the cardiovascular effects induced by morphine has 
been investigated. The injection of endomorphin-2 
which is an endogenous opioids to MNTS 
(cardiovascular control center in medulla oblongata 
and the afferent pathways entering the baroreflex 
network) in the rat would cause stimulatory effect on 
the baroreflex and creates bradycardia and decreases 
MAP subsequently, while if the baroreflex was 
stimulated prior to the injection of endomorphin-2 to 
MNTS, the injection of E-2 would reduce the 
response of baroreflex and the induced bradycardia 
and hypotension would be decreased. The activation 
of the Mu opioids receptors in MNTS would reduce 
the baroreflex response.24 So it seems that the chronic 
injection of morphine by activating the Mu opioids 
receptors reduced the BRS response which can justify 
the results of the present study. In a similar study, it 
was seen that opioids and gabaergic systems in the 
MNTS have the inhibitory effect on baroreflex25,26 
whereas it is expected that endomorphins have 
inhibitory effects on neurons and may increase the 
blood pressure and heart rate.27,28 Probably the 
opioids effect on BRS is influenced by the type of 
stimulated receptor. 
Endogenous and exogenous opioids regulate the 
performance of BRS through effects on central 
opioids receptors including Mu and Kappa.29  It is 
possible that the increase of the BRS which was 
observed in this study after an acute injection of 
morphine was due to the stimulation of Kappa and 
Sigma receptors and the chronic injection stimulates 
the Mu receptor, although the reduction of BRS in 
this regard was not significant. In another study, a 
kappa agonist increased the HR through its central 
and peripheral receptors but had a minimal effect on 
blood pressure which was the specific effect of Kappa 
agonist whereas the Mu agonist did not have this 
effect.23 It is anticipated that the rate of BRS 
stimulation also plays a role in the kind of impact. It 
appears that the activation of baroreceptor causes a 
release of peptide opioids in the brainstem which 
increases the BRS. Moreover, by activation of 
peripheral opioid system, the BRS may be reduced 
possibly by preventing the release of norepinephrine 
from the heart neurons.30 
Conclusion 
It seems that the details of opioids' effects on the body 
including the cardiovascular system are dependent on Effects of morphine on the cardiovascular system 
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the type of opioid agent and consequently, on the type 
of stimulated receptor. The endogenous opioids are 
responsible for high blood pressure (including three 
main categories: encephalin: The Delta receptor agonist 
- Beta-endorphins: Mu and Kappa and Delta strong 
agonist receptors - dynorphin: Kappa strong receptor 
agonist and Mu relatively strong antagonist) by creating 
stimulatory effects. Both acute and chronic morphine 
injection changed the blood pressure in order to 
decrease it properly. 
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